Anne-emmanuelle Fargeton
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.
Journal: British journal of clinical pharmacology
Published: June 11, 2025
Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trial.
Journal: Angiogenesis
Published: September 04, 2024
BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study.
Journal: Therapeutic advances in hematology
Published: July 12, 2024
Ultra-low dose chest CT for the diagnosis of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
Journal: Diagnostic and interventional imaging
Published: September 28, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Journal: Journal of internal medicine
Published: August 18, 2023
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
Journal: European journal of medical genetics
Published: November 30, 2021
Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: November 19, 2021
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
Journal: Journal of clinical medicine
Published: April 06, 2020
Classifying Ectopia Lentis in Marfan Syndrome into Five Grades of Increasing Severity.
Journal: Journal of clinical medicine
Published: January 16, 2020
Hereditary hemorrhagic telangiectasia and health-related quality of life: a qualitative investigation.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: January 02, 2020
Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
Journal: Scientific reports
Published: May 23, 2019
Last Updated: 09/26/2026